7L9X | pdb_00007l9x

Structure of VPS4B in complex with an allele-specific covalent inhibitor


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.81 Å
  • R-Value Free: 
    0.267 (Depositor), 0.268 (DCC) 
  • R-Value Work: 
    0.209 (Depositor), 0.211 (DCC) 
  • R-Value Observed: 
    0.215 (Depositor) 

Starting Model: experimental
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 7L9X

Ligand Structure Quality Assessment 


This is version 1.3 of the entry. See complete history

Literature

A chemical genetics approach to examine the functions of AAA proteins.

Cupido, T.Jones, N.H.Grasso, M.J.Pisa, R.Kapoor, T.M.

(2021) Nat Struct Mol Biol 28: 388-397

  • DOI: https://doi.org/10.1038/s41594-021-00575-9
  • Primary Citation Related Structures: 
    7L9X

  • PubMed Abstract: 

    The structural conservation across the AAA (ATPases associated with diverse cellular activities) protein family makes designing selective chemical inhibitors challenging. Here, we identify a triazolopyridine-based fragment that binds the AAA domain of human katanin, a microtubule-severing protein. We have developed a model for compound binding and designed ASPIR-1 (allele-specific, proximity-induced reactivity-based inhibitor-1), a cell-permeable compound that selectively inhibits katanin with an engineered cysteine mutation. Only in cells expressing mutant katanin does ASPIR-1 treatment increase the accumulation of CAMSAP2 at microtubule minus ends, confirming specific on-target cellular activity. Importantly, ASPIR-1 also selectively inhibits engineered cysteine mutants of human VPS4B and FIGL1-AAA proteins, involved in organelle dynamics and genome stability, respectively. Structural studies confirm our model for compound binding at the AAA ATPase site and the proximity-induced reactivity-based inhibition. Together, our findings suggest a chemical genetics approach to decipher AAA protein functions across essential cellular processes and to test hypotheses for developing therapeutics.


  • Organizational Affiliation
    • Laboratory of Chemistry and Cell Biology, The Rockefeller University, New York, NY, USA.

Macromolecule Content 

  • Total Structure Weight: 50.04 kDa 
  • Atom Count: 2,326 
  • Modeled Residue Count: 300 
  • Deposited Residue Count: 446 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Vacuolar protein sorting-associated protein 4B446Homo sapiensMutation(s): 1 
Gene Names: VPS4BSKD1VPS42MIG1
EC: 3.6.4.6
UniProt & NIH Common Fund Data Resources
Find proteins for O75351 (Homo sapiens)
Explore O75351 
Go to UniProtKB:  O75351
PHAROS:  O75351
GTEx:  ENSG00000119541 
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupO75351
Sequence Annotations
Expand
Reference Sequence

Small Molecules

Ligands 2 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
XQV
(Subject of Investigation/LOI)

Query on XQV



Download:Ideal Coordinates CCD File
B [auth A]N-{3-[(8-phenyl[1,2,4]triazolo[1,5-a]pyridin-2-yl)amino]phenyl}propanamide
C21 H19 N5 O
LFWOSNJNBDQUPD-UHFFFAOYSA-N
SO4

Query on SO4



Download:Ideal Coordinates CCD File
C [auth A]SULFATE ION
O4 S
QAOWNCQODCNURD-UHFFFAOYSA-L

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.81 Å
  • R-Value Free:  0.267 (Depositor), 0.268 (DCC) 
  • R-Value Work:  0.209 (Depositor), 0.211 (DCC) 
  • R-Value Observed: 0.215 (Depositor) 
Space Group: P 65
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 77.876α = 90
b = 77.876β = 90
c = 132.826γ = 120
Software Package:
Software NamePurpose
PHENIXrefinement
XDSdata reduction
Cootmodel building
XDSdata scaling
PHENIXphasing

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

& Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS)United States5 T32 CA 9673-40

Revision History  (Full details and data files)

  • Version 1.0: 2021-04-14
    Type: Initial release
  • Version 1.1: 2021-04-28
    Changes: Database references
  • Version 1.2: 2023-10-18
    Changes: Data collection, Database references, Refinement description
  • Version 1.3: 2024-10-30
    Changes: Structure summary